- Home
- VHC vs IMA Comparison
VHC vs IMA Comparison
Compare VHC & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VHC | IMA |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 65.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VHC | IMA |
|---|---|---|
| Price | $19.08 | $6.55 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 16.3K | ★ 41.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.60 | $5.70 |
| 52 Week High | $29.00 | $18.00 |
Technical Indicators
Market Signals| Indicator | VHC | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 45.04 |
| Support Level | $17.56 | $6.81 |
| Resistance Level | $21.32 | $7.21 |
| Average True Range (ATR) | 1.45 | 0.39 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 50.11 | 15.09 |
Price Performance
Historical ComparisonAbout VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.